Dialysis drug pioneers

Year invested

Invizius is on a mission to transform lives globally by improving patient outcomes in dialysis and other extra-corporeal treatments. Its core patented technology, which applies an invisibility cloak to the surfaces of the devices, aims to reduce inflammatory responses in dialysis patients which, on average using existing solutions, reduces a patient’s remaining life expectancy to one third of what it would otherwise be.

Meet the team

Related articles

How to survive and thrive in 2021 as a VC firm according to Downing Ventures - article

In 2021, it has never been more important for venture capital firms to be able to differentiate.

Downing Ventures Leads Investment in BBC Maestro that Launches Today

Downing Ventures is excited to announce its role as lead investor in BBC Maestro, a new e-learning service des...

What is next for UK Edtech in the pandemic era?

As the new demands of home learning have accelerated the industry’s product offerings and processes, the full ...